Braskem SA
BOVESPA:BRKM5
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.26
14.89
|
| Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Braskem SA
Braskem SA stands as a dynamic force in the global petrochemical industry, emerging from a robust foundation in Brazil's industrial landscape. Formed in 2002 through the strategic merger of six chemical companies linked to Odebrecht and the Mariani Group, Braskem leveraged the combined expertise and resources of its predecessors to scale rapidly. The company's operations are deeply integrated across the petrochemical value chain. By transforming raw materials like ethylene and propylene into a diverse array of thermoplastics, Braskem taps into various industry needs, ranging from packaging solutions to automotive components. Its production facilities, strategically located near sources of raw materials, allow for efficient conversion and logistics, reinforcing its position in the Americas and beyond.
Braskem's growth narrative is marked by its innovative approach to sustainability, particularly through its ambitious investments in bio-based ethylene derived from sugarcane. This “green” polyethylene, a pioneering move in the industry, not only caters to environmentally conscious markets but also positions the company as a leader in sustainable practices. Financially, Braskem's revenue streams are diversified through its international presence, with a significant portion derived from exports, benefiting from a competitive cost structure thanks largely to Brazil's abundant raw material resources. By continually refining its production processes and expanding its portfolio of high-value-added products, Braskem not only maintains its market relevance but also ensures a steady flow of revenue across different economic cycles.
Braskem SA stands as a dynamic force in the global petrochemical industry, emerging from a robust foundation in Brazil's industrial landscape. Formed in 2002 through the strategic merger of six chemical companies linked to Odebrecht and the Mariani Group, Braskem leveraged the combined expertise and resources of its predecessors to scale rapidly. The company's operations are deeply integrated across the petrochemical value chain. By transforming raw materials like ethylene and propylene into a diverse array of thermoplastics, Braskem taps into various industry needs, ranging from packaging solutions to automotive components. Its production facilities, strategically located near sources of raw materials, allow for efficient conversion and logistics, reinforcing its position in the Americas and beyond.
Braskem's growth narrative is marked by its innovative approach to sustainability, particularly through its ambitious investments in bio-based ethylene derived from sugarcane. This “green” polyethylene, a pioneering move in the industry, not only caters to environmentally conscious markets but also positions the company as a leader in sustainable practices. Financially, Braskem's revenue streams are diversified through its international presence, with a significant portion derived from exports, benefiting from a competitive cost structure thanks largely to Brazil's abundant raw material resources. By continually refining its production processes and expanding its portfolio of high-value-added products, Braskem not only maintains its market relevance but also ensures a steady flow of revenue across different economic cycles.
EBITDA Rebound: Recurring EBITDA rose sharply to $150 million, up 104% from the previous quarter, helped by higher-value sales, operational improvements, and resilience initiatives.
Prolonged Industry Downturn: Management highlighted a challenging global petrochemical cycle with weak demand, excess capacity, and historically low spreads, projecting no recovery until the end of the decade.
Liquidity & Leverage: Cash position stood at $1.3 billion, covering debt maturities for 27 months; corporate leverage rose to 14.7x, mainly due to lower EBITDA.
Transformation Projects: The board approved the Transform Rio project, expanding ethylene/PE capacity by 220,000 tonnes per year for an estimated BRL 4.2 billion, with up to $200 million in potential annual EBITDA.
Regulatory & Fiscal Developments: The PRESIQ bill, offering significant fiscal benefits to the chemical industry, is advancing in the Brazilian Senate, with potential EBITDA impacts of $280–$300 million from 2026.
Alagoas Settlement: Braskem signed a BRL 1.2 billion agreement with the state of Alagoas to resolve liabilities from a geological event, with payments spread mainly after 2030.
Operational Resilience: Over 700 initiatives launched under the resilience program captured $240 million in EBITDA and $330 million in cash year-to-date.
Outlook & Strategy: Management expects muted demand, ongoing global oversupply, and sustained margin pressure, prompting continued cost reductions and asset transformation.